NL-OMON27439Other不适用
A Phase 1, Single-Center, Double-Blind, Placebo Controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous ABP-700 after a Single Ascending Bolus Dose
Annovation Biopharma(University Medical Center Groningen)0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- Other
- 发起方
- 入组人数
- 60
研究概览
简要总结
one
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Healthy, adult, men and women, 18-45 years of age, inclusive.
- •2.Continuous non-smoker who has not used nicotine-containing products for at least 6 months prior to the first dose.
排除标准
- •1.History or presence of significant cardiovascular disease, or cardiovascular disease risk factors, hyperlipidemia, coronary artery disease, or any known genetic pre disposition to cardiac arrhythmia (including long QT syndrome.)
- •2.History or presence of significant pulmonary, hepatic, renal, hematological, gastrointestinal, endocrine, immunologic, dermatologic, neurological (inclusive of any seizure disorder), or psychiatric disease.
研究者
相似试验
已完成
不适用
A Phase 1, Single-Center, Double-Blind, Placebo Controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous ABP-700 after a Single Ascending Bolus DoseanesthesiaNL-OMON40883Annovation Biopharma, Inc.60
Unknown
不适用
A Phase 1, Single-Center, Single-Blind, Placebo and Propofol Controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous (IV) Infusion Doses of ABP-700Preliminary safety studyNL-OMON25748Annovation Biopharma, University Medical Center Groningen (UMCG)48
进行中（未招募）
1 期
Study of effects of AUT00206 in healthy males - ketamine challengeSchizophreniaEUCTR2016-000216-14-GBAutifony Therapeutics Limited
已完成
1 期
A Phase 1 Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of the AUM001 in Healthy VolunteersACTRN12620000572965AUM Biosciences Pty Ltd24
已完成
1 期
A Phase 1 clinical trial to evaluate safety and effectiveness of ZIKA vaccine in healthy adults.CTRI/2017/05/008539Bharat Biotech International Ltd48